Patterson Companies (PDCO) | Financial Analysis & Statements
Patterson Companies Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jan 2025Income Metrics
Revenue
1.6B
Gross Profit
320.8M
20.40%
Operating Income
45.4M
2.89%
Net Income
31.2M
1.98%
EPS (Diluted)
$0.35
Balance Sheet Metrics
Total Assets
2.8B
Total Liabilities
1.8B
Shareholders Equity
989.9M
Debt to Equity
1.86
Cash Flow Metrics
Operating Cash Flow
-289.0M
Free Cash Flow
-296.6M
Revenue & Profitability Trend
Quarter Income Flow
Jan 31, 2025
Annual Income Flow
2024
Patterson Companies Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 6.6B | 6.5B | 6.5B | 5.9B | 5.5B |
| Cost of Goods Sold | 5.2B | 5.1B | 5.2B | 4.7B | 4.3B |
| Gross Profit | 1.4B | 1.4B | 1.3B | 1.2B | 1.2B |
| Gross Margin % | 21.0% | 21.2% | 19.8% | 20.4% | 21.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 252.9M | 276.0M | 157.0M | 210.6M | 102.9M |
| Operating Margin % | 3.9% | 4.3% | 2.4% | 3.6% | 1.9% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 44.9M | 33.6M | 20.3M | 24.3M | 41.8M |
| Other Non-Operating Income | 35.0M | 27.8M | 129.5M | 13.6M | -651.6M |
| Pre-tax Income | 243.1M | 270.2M | 266.3M | 199.9M | -590.4M |
| Income Tax | 57.5M | 63.6M | 64.5M | 44.8M | -1.0M |
| Effective Tax Rate % | 23.7% | 23.5% | 24.2% | 22.4% | 0.0% |
| Net Income | 185.5M | 206.6M | 201.7M | 155.1M | -589.4M |
| Net Margin % | 2.8% | 3.2% | 3.1% | 2.6% | -10.7% |
| Key Metrics | |||||
| EBITDA | 341.1M | 359.7M | 239.0M | 289.5M | 185.1M |
| EPS (Basic) | $2.00 | $2.14 | $2.09 | $1.63 | $-6.25 |
| EPS (Diluted) | $1.98 | $2.12 | $2.06 | $1.61 | $-6.25 |
| Basic Shares Outstanding | 92969000 | 97027000 | 97277000 | 95599000 | 94154000 |
| Diluted Shares Outstanding | 92969000 | 97027000 | 97277000 | 95599000 | 94154000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Patterson Companies Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 114.5M | 159.7M | 142.0M | 143.2M | 77.9M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 547.3M | 477.4M | 447.2M | 449.2M | 416.5M |
| Inventory | 782.9M | 795.1M | 785.6M | 736.8M | 812.2M |
| Other Current Assets | 334.1M | 351.0M | 304.2M | 286.7M | 236.1M |
| Total Current Assets | 1.8B | 1.8B | 1.7B | 1.6B | 1.5B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 122.3M | 93.0M | 70.7M | 77.2M | 79.0M |
| Goodwill | 505.9M | 544.7M | 533.9M | 559.5M | 591.0M |
| Intangible Assets | 193.3M | 231.9M | 252.6M | 279.6M | 313.5M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 250.7M | 242.5M | 246.3M | 313.8M | 234.9M |
| Total Non-Current Assets | 1.1B | 1.1B | 1.1B | 1.1B | 1.2B |
| Total Assets | 2.9B | 2.9B | 2.7B | 2.8B | 2.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 745.4M | 725.0M | 681.3M | 609.3M | 862.1M |
| Short-term Debt | 341.6M | 109.4M | 58.3M | 186.0M | 30.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 1.3B | 1.1B | 1.0B | 1.1B | 1.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 421.4M | 518.6M | 531.9M | 535.9M | 637.6M |
| Deferred Tax Liabilities | 104.5M | 119.1M | 120.4M | 124.5M | 134.5M |
| Other Non-Current Liabilities | 36.6M | 37.5M | 31.0M | 36.8M | 31.8M |
| Total Non-Current Liabilities | 562.4M | 675.3M | 683.3M | 697.2M | 804.0M |
| Total Liabilities | 1.9B | 1.8B | 1.7B | 1.8B | 1.9B |
| Equity | |||||
| Common Stock | 897.0K | 964.0K | 968.0K | 968.0K | 959.0K |
| Retained Earnings | 831.5M | 972.1M | 921.7M | 855.7M | 799.7M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.0B | 1.1B | 1.0B | 964.7M | 836.4M |
| Key Metrics | |||||
| Total Debt | 762.9M | 628.0M | 590.2M | 721.9M | 668.3M |
| Working Capital | 446.2M | 697.8M | 663.4M | 526.3M | 467.9M |
Balance Sheet Composition
Patterson Companies Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 185.5M | 206.6M | 201.7M | 155.1M | -589.4M |
| Depreciation & Amortization | 88.2M | 83.7M | 82.0M | 78.9M | 82.2M |
| Stock-Based Compensation | 17.9M | 15.5M | 23.8M | - | - |
| Working Capital Changes | -1.1B | -1.0B | -1.2B | -1.1B | -419.1M |
| Operating Cash Flow | -789.1M | -736.6M | -854.3M | -849.4M | -949.1M |
| Investing Activities | |||||
| Capital Expenditures | -67.6M | -64.2M | -38.3M | -25.8M | -41.8M |
| Acquisitions | -1.1M | -33.3M | -19.8M | 0 | 0 |
| Investment Purchases | 0 | -15.0M | 0 | 0 | - |
| Investment Sales | 0 | 0 | 75.9M | 396.0K | 0 |
| Investing Cash Flow | 959.5M | 901.6M | 1.2B | 810.7M | 499.1M |
| Financing Activities | |||||
| Share Repurchases | -229.5M | -55.5M | -35.0M | 0 | 0 |
| Dividends Paid | -98.3M | -101.3M | -101.1M | -75.2M | -100.4M |
| Debt Issuance | - | - | 0 | 0 | 300.0M |
| Debt Repayment | -36.0M | -1.5M | -100.8M | 0 | -460.8M |
| Financing Cash Flow | -215.9M | -126.5M | -253.2M | -22.6M | -271.2M |
| Free Cash Flow | -857.0M | -819.1M | -1.0B | -756.3M | -285.4M |
| Net Change in Cash | -45.5M | 38.5M | 131.5M | -61.4M | -721.2M |
Cash Flow Trend
Patterson Companies Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
20.48
Forward P/E
12.43
Price to Book
2.80
Price to Sales
0.43
PEG Ratio
12.43
Profitability Ratios
Profit Margin
2.13%
Operating Margin
3.06%
Return on Equity
14.11%
Return on Assets
4.85%
Financial Health
Current Ratio
1.41
Debt to Equity
88.87
Beta
0.72
Per Share Data
EPS (TTM)
$1.53
Book Value per Share
$11.19
Revenue per Share
$73.53
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PDCO | 2.8B | 20.48 | 2.80 | 14.11% | 2.13% | 88.87 |
| McKesson | 103.2B | 24.33 | -1,040.14 | -194.51% | 1.09% | -88.23 |
| Cencora | 60.6B | 37.46 | 31.84 | 133.47% | 0.50% | 472.58 |
| Henry Schein | 9.0B | 23.94 | 2.79 | 8.70% | 3.02% | 71.74 |
| Cardinal Health | 48.2B | 29.50 | -17.89 | -59.26% | 0.68% | -3.34 |
| Owens & Minor | 184.1M | - | - | -196.39% | -12.45% | -4.86 |
Financial data is updated regularly. All figures are in the company's reporting currency.
